High-Multiplex Single-Cell Imaging Analysis Reveals Tumor Immune Contexture Associated with Clinical Outcomes After CAR T-cell Therapy

Researchers designed a highly multiplexed imaging mass cytometry panel to simultaneously quantify 31 biomarkers from 13 patients with relapsed/refractory DLBCL who received CAR19/22 T cell therapy.